Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Thymidine and deoxycytidine

EU orphan designation number: EU/3/17/1870   
Active ingredient: Thymidine and deoxycytidine
Indication: Treatment of mitochondrial DNA depletion syndrome, myopathic form
Sponsor: Pharma Gateway AB
Johanneslundsvägen 2, Hammarby, 194 61 Upplands Väsby, Stockholms Lan, Sverige

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
24/04/2017 Orphan designation EMA/OD/317/16 (2017)2789 of 20/04/2017
12/07/2017 Corrigendum (2017)2789 of 20/04/2017
17/08/2018 Transfer of orphan designation EMA/OD/317/16/T/01 (2018)5403 of 3/08/2018